As an important tool for biomedical research, the IC50 cell activity assay platform of InnoModels Biotechnology (Beijing) Co., Ltd. provides powerful technical support for drug discovery, disease mechanism research and other fields. With its rich experience in drug discovery and development, advanced experimental technology and extensive cooperative network, the platform provides researchers with efficient, accurate and reliable cell activity assay services.
1、Rich experience in drug discovery and development
InnoModels Biotechnology has an experienced drug discovery team with profound knowledge in drug screening, optimization and mechanism of action research. This enables the company to have high accuracy and reliability in the determination of IC50 values. In addition, the laboratory staff has more than 15 years of experience and specializes in IC50 determination and cell culture technology, which provides professional and stable technical support for cell activity detection.
2、Advanced experimental technology
InnoModels Biotechnology adopts advanced experimental techniques, such as high-content imaging system and bioinformatics analysis, to precisely analyze the interaction between drugs and targets. These technologies help to improve the accuracy and sensitivity of IC50 value determination, providing researchers with more accurate and reliable experimental data.
3、Wide cooperation network
InnoModels Biotechnology has established an extensive cooperation network with a number of research institutions and enterprises at home and abroad, which promotes the progress of biomedical research by sharing resources and technologies. This mode of cooperation not only helps to enhance the company's R&D strength, but also provides researchers with more opportunities for cooperation and promotes the transformation and application of research results.

4、Strict data quality control
InnoModels Biotechnology attaches great importance to the quality of data and the safety of experiments. All cells are tested for STR (Short Tandem Repeat Sequence) before use to ensure the accuracy of cell identity. In addition, the company regularly tests for mycoplasma and chlamydia in the cell culture solution to ensure the reliability and safety of the experiments. These measures provide researchers with high-quality and credible experimental data, and provide strong support for drug development and disease mechanism research.
5、Diverse cell line selection
InnoModels Biotechnology has more than 400 human-derived tumor cell lines, covering a wide range of cancer types and subtypes. This means that researchers can easily select cell lines on the platform that suit their research needs, whether for anti-cancer drug screening or mechanism studies. This diverse selection of cell lines provides researchers with a broader research space and helps promote innovation in the biomedical field.
6、Stable and Repeatable Data
InnoModels' platform is known for its stable and reproducible data. The company strictly follows a standardized experimental process to ensure that the results of each experiment are credible. This stability and reproducibility provides researchers with reliable data support, allowing them to analyze and compare data with confidence and support their research.
In summary, the IC50 cell activity assay platform of InnoModels Biotechnology has become a powerful assistant for biomedical research with its rich experience in drug discovery and development, advanced experimental technology, extensive collaborative network, stringent data quality control, diverse selection of cell lines, and stable and reproducible data. The platform provides powerful technical support for drug discovery, disease mechanism research and other fields, and makes important contributions to the advancement of biomedical field.